{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:49:02Z","timestamp":1724658542553},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,12]]},"DOI":"10.7759\/cureus.52155","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T12:43:06Z","timestamp":1705063386000},"source":"Crossref","is-referenced-by-count":1,"title":["Delayed Presentation of Pityriasis Rubra Pilaris in a Patient on Treatment With Ponatinib"],"prefix":"10.7759","author":[{"given":"Marissa M","family":"Yaldo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey","family":"Olds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Hengy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Moossavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Other papulosquamous disorders","author":"Wood GS","year":"2018","unstructured":"Wood GS, Reizner GT. Other papulosquamous disorders. Dermatology. 4th Edn. Cerroni L (ed): Elsevier Health Sciences, Amsterdam, Netherlands; 2018. 161-74."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002344","article-title":"Ponatinib-associated cutaneous eruptions\u2014a case series and review of clinicopathologic findings","volume":"45","author":"Weber I","year":"2023","unstructured":"Weber I, Gloss C, Castillo B, Smith E. Ponatinib-associated cutaneous eruptions\u2014a case series and review of clinicopathologic findings. Am J Dermatopathol. 2023, 45:64-8. 10.1097\/DAD.0000000000002344","journal-title":"Am J Dermatopathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2018.04.009","article-title":"A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor [Article in French]","volume":"145","author":"Krygier J","year":"2018","unstructured":"Krygier J, Leemans G, Forsyth R, de Becker A, Gutermuth J, Grosber M. A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor [Article in French]. Ann Dermatol Venereol. 2018, 145:665-70. 10.1016\/j.annder.2018.04.009","journal-title":"Ann Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086","article-title":"Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial","volume":"132","author":"Cortes JE","year":"2018","unstructured":"Cortes JE, Kim DW, Pinilla-Ibarz J, et al.. Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial. Blood. 2018, 132:393-404. 10.1182\/blood-2016-09-739086","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40800-017-0055-y","article-title":"Ichthyosiform pityriasis rubra pilaris-like eruption secondary to ponatinib therapy: case report and literature review","volume":"4","author":"Eber AE","year":"2017","unstructured":"Eber AE, Rosen A, Oberlin KE, Giubellino A, Romanelli P. Ichthyosiform pityriasis rubra pilaris-like eruption secondary to ponatinib therapy: case report and literature review. Drug Saf Case Rep. 2017, 4:19. 10.1007\/s40800-017-0055-y","journal-title":"Drug Saf Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001822","article-title":"Pityriasis rubra pilaris-like reaction induced by a tyrosine kinase inhibitor, the ponatinib","volume":"43","author":"Mongereau M","year":"2021","unstructured":"Mongereau M, Hillion B, Fouillard L, Boivin JF, Gaudron S. Pityriasis rubra pilaris-like reaction induced by a tyrosine kinase inhibitor, the ponatinib. Am J Dermatopathol. 2021, 43:394-5. 10.1097\/DAD.0000000000001822","journal-title":"Am J Dermatopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.052","article-title":"Drugs associated with development of pityriasis rubra pilaris: a systematic review","volume":"84","author":"Mufti A","year":"2021","unstructured":"Mufti A, Lytvyn Y, Maliyar K, Sachdeva M, Yeung J. Drugs associated with development of pityriasis rubra pilaris: a systematic review. J Am Acad Dermatol. 2021, 84:1071-81. 10.1016\/j.jaad.2020.07.052","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.07.039","article-title":"Clinical course, diagnostic patterns, and treatment outcomes in patients with pityriasis rubra pilaris","volume":"87","author":"Ji-Xu A","year":"2022","unstructured":"Ji-Xu A, Lei DK, Maloney NJ, Worswick S. Clinical course, diagnostic patterns, and treatment outcomes in patients with pityriasis rubra pilaris. J Am Acad Dermatol. 2022, 87:1450-1. 10.1016\/j.jaad.2022.07.039","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0091","article-title":"Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris. A case series of 100 patients","volume":"152","author":"Ross NA","year":"2016","unstructured":"Ross NA, Chung HJ, Li Q, Andrews JP, Keller MS, Uitto J. Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris. A case series of 100 patients. JAMA Dermatol. 2016, 152:670-5. 10.1001\/jamadermatol.2016.0091","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_918_19","article-title":"Ponatinib-induced atypical pityriasis rubra pilaris-like rash","volume":"86","author":"Kamat D","year":"2020","unstructured":"Kamat D, Chatterjee D, Mahajan R. Ponatinib-induced atypical pityriasis rubra pilaris-like rash. Indian J Dermatol Venereol Leprol. 2020, 86:688-90. 10.4103\/ijdvl.IJDVL_918_19","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/11530070-000000000-00000","article-title":"Pityriasis rubra pilaris: a review of diagnosis and treatment","volume":"11","author":"Klein A","year":"2010","unstructured":"Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010, 11:157-70. 10.2165\/11530070-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection","volume":"133","author":"Miralles ES","year":"1995","unstructured":"Miralles ES, N\u00fa\u00f1ez M, De Las Heras ME, P\u00e9rez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol. 1995, 133:990-3. 10.1111\/j.1365-2133.1995.tb06939.x","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths WA","year":"1980","unstructured":"Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol. 1980, 5:105-12. 10.1111\/j.1365-2230.1980.tb01676.x","journal-title":"Clin Exp Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217047-delayed-presentation-of-pityriasis-rubra-pilaris-in-a-patient-on-treatment-with-ponatinib","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:28Z","timestamp":1707509488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217047-delayed-presentation-of-pityriasis-rubra-pilaris-in-a-patient-on-treatment-with-ponatinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.52155","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}